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debrile  reactions  are  a  group  of  serological  agglutination
ssays  which  originated  in  the  beginning  of  the  last  cen-
ury.  They  are  still  used  in  developing  countries  because
f  their  speed  and  technically  ease  of  application,  as  well
s  their  low  cost.  For  almost  100  years,  these  studies  were
sed  for  the  diagnosis  of  diseases  caused  by  the  salmonella
acteria,  such  as  typhoid  and  paratyphoid  fever  (Widal  reac-
ion)  and  brucellosis  (Huddleston  reaction),  as  well  as  for  the
etection  of  some  diseases  caused  by  rickettsias  (Weil--Felix
eaction  in  Proteus  OX19  infections).  The  presence  of  fever
n  the  clinical  picture  of  all  these  infectious  ailments  was
he  origin  of  the  ‘‘febrile  reactions’’  denomination  and  the
‘febrile  agglutinins  panel’’  concept  for  patients  with  fever
f  unknown  origin;  both  terms  are  semantically  and  clinically
nappropriate.
Nowadays  febrile  reactions  are  within  the  group  of  assays
onsidered  obsolete.  They  were  undoubtedly  of  great  use
n  the  past;  however,  for  more  than  30  years,  they  have
een  substituted  by  other  methodologies,  and  are  now  a
art  of  the  history  of  medicine.  When  these  assays  were
nitially  implemented,  sanitary  conditions  in  our  country
ere  poor.  Consequently,  these  infectious  diseases  had  a
igh  prevalence.  Today,  even  though  eradication  of  these
ilments  has  not  been  accomplished,  it  has  been  signif-
cantly  lowered.  However,  there  are  still  endemic  zones,
ainly  for  the  salmonella  and  brucella  bacterias.  In  bio-
tatistics,  the  lowering  of  the  prevalence  of  a  disease∗ Tel.: +52 81 83481036/11551302.
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ecrease  in  the  predictive  diagnostic  values  for  a  lab  assay.
his  concept  is  evidently  applicable  for  febrile  reactions  as
ell.
This  is  the  reason  for  which  these  studies  have  signiﬁ-
antly  decreased  in  their  diagnostic  sensitivity,  speciﬁcity
nd  predictive  values  indicators.
Additionally,  there  are  two  other  more  important  factors
hich  limit  the  diagnostic  usefulness  of  febrile  reactions  as
aboratory  assays.  The  ﬁrst  one  refers  to  the  error  inher-
nt  in  the  agglutination  analytical  method,  the  second  one
o  the  fact  that,  in  the  majority  of  cases,  the  physician
akes  an  inadequate  interpretation  of  the  results  of  said
tudies.
nalytical method
he  commercial  reactive  consists  of  a  suspension  of  dead
acteria  which  are  reacted  with  serial  dilutions  from  the
atient’s  serum.  Because  this  is  an  agglutination  assay,
‘human  error’’  is  present,  since  no  analytical  measurement
nstruments  are  used  and  the  reading  of  results  depends  on
he  visual  appreciation  of  the  observer.  The  last  dilution  pre-
enting  agglutination  from  the  patient’s  serum  is  the  result
f  the  antibodies  titer  of  the  report.  Technically,  a  subtle
ifference  between  the  last  two  tubes  of  the  agglutina-
ion  reaction  may  not  be  detected  between  two  different
bservers,  thus  this  variation  may  cause  the  possibility  of
wo  discrepant  results  of  the  same  sample,  whose  titers  may
ary  (i.e.  between  1:160  and  1:320).
asson Doyma Me´xico S.A. This is an open access article under the
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lFebrile  reactions  in  the  21st  century  
Major  considerations  regarding  febrile  reactions  are:
1.  The  standardization  of  commercial  antigen  is  very  deﬁ-
cient.  This  explains  the  discrepant  results  with  the  same
serum  sent  to  different  clinical  laboratories;  even  when
using  different  batches  of  the  same  commercial  brand
antigen,  there  may  be  different  results  in  antibody
titling.
Lack  of  appropriate  commercial  antigen  standardiza-
tion  also  generates  a  lack  of  proper  internal  quality
control  in  clinical  laboratories,  which  do  not  have  trust-
worthy  accuracy  and  reproducibility  parameters  for
these  assays.  According  to  the  above,  within  the  exter-
nal  quality  controls  of  serum  sample  exchange  between
different  laboratories,  there  is  an  evident  lack  of  con-
cordance  in  the  results.
2.  Another  technical  problem  that  may  occur,  speciﬁcally  in
some  patients  with  brucellosis,  is  false  negatives,  caused
by  the  zone  phenomenon.  This  eventuality  is  not  exclu-
sive  to  febrile  reactions,  since  it  may  occur  in  every
type  of  agglutination  or  precipitation  reaction.  This  is  a
result  of  the  lack  of  equivalencies  between  the  amounts
of  commercial  antigen  and  the  antibody  present  in  the
patient’s  serum.  This  is  a  prozone  phenomenon,  or  anti-
body  excess.  In  order  to  identify  this  possible  eventuality,
serial  dilutions  of  the  patient’s  serum  in  the  presence  of
the  same  amount  of  commercial  bacterial  antigen  will
have  to  be  performed.
Considerations of the clinical interpretation of
febrile reactions
1.  The  main  problem  of  febrile  reactions  is  that  when
interpreting  results,  it  has  not  been  possible  to  have
a  uniformed  and  standardized  criteria  of  which  anti-
body  titer  is  to  be  considered  a  signiﬁcant  cut-off  point
which  deﬁnitely  establishes  the  diagnostic  criteria  of  the
disease.  This  has  led  some  doctors  to  prescribe  an  antimi-
crobial  therapy  without  justiﬁcation,  for  the  mere  reason
of  presenting  reactivity  in  any  of  the  assays.  The  latter
occurs  even  in  asymptomatic  patients.
2.  An  antibody  titer  by  itself  cannot  be  associated  with  a
deﬁnite  diagnosis.  In  the  endemic  areas  of  the  disease,
a  signiﬁcant  interpretation  of  the  antibody  titer  results
is  difﬁcult.
3.  Febrile  reactions  may  show  positive  results  in  a  healthy
population,  and  antibodies’  titration  values  may  also
present  signiﬁcant  variations  with  age.  This  can  be
explained  by  many  different  concepts,  including  analyt-
ical  errors,  immunological  memory  in  patients  who  had
the  disease,  anamnestic  immune  responses,  vaccinated
individuals,  or  by  the  presence  of  unspeciﬁed  crossed
reactions  with  types  of  different  bacteria  which  have
been  described  in  Widal  reactions  with  enterobacteria,
in  Huddleson  with  tularemia,  cholera  and  certain  types
of  yersinia  enterocolitica,  as  well  as  the  Weil  Felix  reac-
tion  in  patients  with  previous  urinary  infections,  or  who
present  leptospirosis  or  Lyme  disease.
4.  There  is  also  the  possibility  of  false  negative  reactions
in  patients  who  are  using  antibiotics  or  who  are  under
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steroid  treatment  or  other  types  of  immunosuppressants.
On  the  other  hand,  in  patients  with  brucellosis,  Hud-
dleson’s  reaction  may  result  in  a  negative  due  to  the
presence  of  the  prozone  effect.  This  is  just  a  techni-
cal  problem  caused  by  the  inhibition  of  the  agglutination
reaction  due  to  an  excess  of  antibodies  in  the  patient’s
serum.  It  is  clear  that  like  in  any  other  laboratory  assay,
all  results  must  be  interpreted  according  to  the  patient’s
symptomatology  and  taking  into  account  the  epidemio-
logical  factors  of  these  diseases.
.  Antibody  detection  in  febrile  reactions  occurs  at  a  late
stage  in  the  evolution  of  the  disease.  This  occurs  between
the  second  and  fourth  week  of  the  clinical  picture  onset.
It  is  not  possible  to  identify  the  type  of  immunoglobulin  in
the  results;  it  may  be  IgM,  IgG  or  IgA.  Once  formed,  the
antibodies  may  persist  after  the  healing  of  the  disease
for  months,  and  even  years.
hat can be rescued from febrile reactions?
e  are  now  able  to  say  that  out  of  the  febrile  reactions
anel,  the  Huddleson  traditional  assay,  despite  some  incon-
eniences  mentioned  above,  is  the  most  useful.  Brucellosis
s  a  worldwide  zoonotic  disease  and  its  main  contamination
ource  is  the  consumption  of  non-pasteurized  dairy  prod-
cts.  Brucella  melitensis  is  the  main  agent  linked  to  the
nfection  of  human  beings.  It  is  a  major  healthcare  issue  in
he  Mediterranean  Basin,  Asia  (speciﬁcally  the  Middle  East)
nd  Africa.  Its  incidence  is  unknown.  However,  between  1
nd  200  cases  per  100,000  habitants  have  been  reported.  In
atin  America,  and  in  our  country,  there  are  well-delimited
ndemic  zones.  Culture  and  isolation  of  the  responsible
gent  in  blood  and  bone  marrow  are  slow  (from  7  to  21
ays),  and  it  can  sometimes  takes  up  to  35  days.  Despite
hese  difﬁculties,  bone  marrow  culture  speciﬁcally  remains
he  gold  standard.  Within  the  clinical  laboratory,  Brucella
s  highly  infectious  and  requires  a  biosafety  level  3  facil-
ty.  Thus,  serology  in  the  early  stages  of  the  disease  is  of
reat  importance  in  diagnosis.  The  traditional  agglutination
ssay  developed  by  Huddleson  has  been  modiﬁed,  standard-
zing  the  commercial  antigen.  Nowadays,  a  strain  of  the
ame  biotype  1  bacteria  is  used  (strain  99s  or  strain  119-
),  acidiﬁed  and  dyed  with  rose  bengal  to  make  the  antigen
ore  visible.  It  is  the  same  plaque  agglutination  assay,  yet
onsistently  more  speciﬁc  in  the  detection  of  antibodies
gainst  Brucella  spp.,  while  it  does  not  discriminate  the  type
f  immunoglobulin  and  it  is  considered  a  good  screening
ssay.  It  is  currently  used  in  blood  banks  in  our  country
n  the  prevention  of  brucellosis  transmission  through  blood
ransfusion.
Since  1970,  and  with  the  advent  of  new  technolo-
ies  like  immunoassays,  these  assays  were  substituted
y  the  speciﬁc  detection  of  IgG  or  IgM  immunoglobulins
gainst  their  respective  infectious  agents.  New  tech-
iques,  such  as  the  immunoenzymatic  assay  or  the  ELISA
Enzyme-Linked  ImmunoSorbent  Assay) and  the  chemi-
uminescence,  have  proven  to  have  greater  diagnostic
ensitivity  and  speciﬁcity,  improving  analytic  reproducibil-
ty  and  accuracy  as  well.  Thus,  nowadays  it  is  possible
o  identify,  in  an  earlier  manner  and  more  speciﬁcally,
he  type  of  antibody  produced  by  the  organism  in  the
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mmune  response  generated  by  bacteria  and  rickettsias,
hich  participate  as  etiological  agents  of  the  diseases
hich  in  the  past  were  diagnosed  through  febrile  reac-
ions.
Molecular  biology  plays,  without  a  doubt,  a  major  role  in
he  diagnosis  of  these  groups  of  infectious  ailments,  as  well
s  in  many  others.  The  challenge  is  the  high  cost  of  the  new
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echnology,  which  is  currently  impeding  its  use  on  a  more
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